Correlation Between ICeram SA and Quantum Genomics
Can any of the company-specific risk be diversified away by investing in both ICeram SA and Quantum Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ICeram SA and Quantum Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ICeram SA and Quantum Genomics SA, you can compare the effects of market volatilities on ICeram SA and Quantum Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ICeram SA with a short position of Quantum Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ICeram SA and Quantum Genomics.
Diversification Opportunities for ICeram SA and Quantum Genomics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ICeram and Quantum is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding ICeram SA and Quantum Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Genomics and ICeram SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ICeram SA are associated (or correlated) with Quantum Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Genomics has no effect on the direction of ICeram SA i.e., ICeram SA and Quantum Genomics go up and down completely randomly.
Pair Corralation between ICeram SA and Quantum Genomics
If you would invest 7.21 in Quantum Genomics SA on October 9, 2024 and sell it today you would earn a total of 0.00 from holding Quantum Genomics SA or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
ICeram SA vs. Quantum Genomics SA
Performance |
Timeline |
ICeram SA |
Quantum Genomics |
ICeram SA and Quantum Genomics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ICeram SA and Quantum Genomics
The main advantage of trading using opposite ICeram SA and Quantum Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ICeram SA position performs unexpectedly, Quantum Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Genomics will offset losses from the drop in Quantum Genomics' long position.ICeram SA vs. Quantum Genomics SA | ICeram SA vs. Biophytis SA | ICeram SA vs. Gensight Biologics SA | ICeram SA vs. Poxel SA |
Quantum Genomics vs. Poxel SA | Quantum Genomics vs. Biophytis SA | Quantum Genomics vs. Gensight Biologics SA | Quantum Genomics vs. OSE Pharma SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
CEOs Directory Screen CEOs from public companies around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |